Aberdeen Group plc

Holdings History for Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX)

Symbol: TVTX on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.03%	-0.03%	$19,806,421	518,357	-449,028	-46%	$38.21	Q4 2025
30 Sep 2025	0.04%	+0%	$23,120,502	967,385	+70,791	+7.9%	$23.90	Q3 2025
30 Jun 2025	0.02%	+0.01%	$13,269,591	896,594	+416,225	+87%	$14.80	Q2 2025
31 Mar 2025	0.02%	+0%	$8,608,212	480,369	+88,369		$17.92	Q1 2025
31 Dec 2024	0.01%	+0.01%	$6,828,640	392,000	+392,000	NEW	$17.42	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.